TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06687603

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EsoCheck
Description: FDA-approved, non-endoscopic, encapsulated swallowable balloon. EsoCheck will produce a sample which will subsequently be tested with EsoGuard assay. The EsoCheck is performed and completed in approximately 5 minutes.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: EsoGuard
Description: Approved laboratory, methylated DNA panel that detects esophageal neoplasia. The EsoGuard assay tests the EsoCheck samples to detect BE in GERD participants.
Study: NCT06704269

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: YTB323
Description: CAR-T cell suspension for intravenous infusion
Study: NCT06768060

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short mindfulness-based intervention
Description: The intervention includes a short mindfulness-based intervention with a duration of 5 minutes. It involves a sitting mediation focused on breath adapted from the existing protocols of the Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT). The intervention is audio-guided and will be delivered via headphones.
Study: NCT05239910

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenalisib
Description: Tenalisib will be administered orally twice daily in a 21-day cycle for 26 cycles (from cycle 1 to cycle 26), CHOP will be administered for 6 cycles (from Cycle 4 to Cycle 9) on Days 1 to 5 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenalisib
Description: Tenalisib will be administered orally twice daily in a 21-day cycle for 26 cycles (from cycle 1 to cycle 26), CHOP will be administered for 6 cycles (from Cycle 4 to Cycle 9) on Days 1 to 5 of each cycle.
Study: NCT05253547

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy climate-friendly dietary guidelines
Description: Personalised climate-friendly healthy dietary recommendations

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy dietary guidelines
Description: Personalised healthy dietary recommendations
Study: NCT02368613

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: DW-3102
Study: NCT06150989

Intervention type: BEHAVIORAL
Intervention: Observational Group
Description: All participants will go through a series of lab-based assessments to evaluate their vascular health. These assessments include: heart rhythm/rate, blood pressure, large blood vessel flow, central aortic blood pressure and pulse wave velocity, brain blood flow, carbon dioxide concentration, flow mediated dilation/blood vessel responsiveness, breathing rate, and cerebral vasomotor reactivity. In addition, venous blood sample will be taken to identify biomarkers that are associated with elevating blood pressure and decreasing blood flow.~The 10-day monitoring period includes a wrist-worn activity tracker and a blood pressure monitor bracelet; a smartphone app that will prompt surveys up to 6 times a day to assess behaviors, social/physical context, mood/stress, and experience of racial discrimination/microaggression. Participants will also collect saliva samples on three consecutive days during the 10-day monitoring period.
Study: NCT06326710

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth
Description: Participants receive 4 sessions of face-to-face or online delivered workshop on how to use the mobile app Outdoor Rehab-Fit to support their daily PA level. In addition to the workshop, participants have to go to public parks to practice what they have learnt from the mobile app.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Talk
Description: Participants receive 4 sessions of face-to-face or online delivered health talks on the benefits different types of modified exercises for frail older adults (chair yoga, seated eight-section brocades, Otago and seated multi-component exercise). Each talk has an experiential session.
Study: NCT05474729

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: minocycline
Description: minocycline capsule 100mg per day orally
Study: NCT02368613

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DW-3102

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DW-3102

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DW-3102
Study: NCT05760664

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group Experimental/Fascial Fitness
Description: Participants will receive twelve treatment sessions, twice a week, for six weeks, lasting 30 minutes per session. The interventions will be applied by a physiotherapist with previous experience and training in the proposed protocols.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Sham/Static stretching exercise
Description: Participants will receive twelve treatment sessions, twice a week, for six weeks, lasting 30 minutes per session. The interventions will be applied by a physiotherapist with previous experience and training in the proposed protocols.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control Group/Placebo
Description: The placebo intervention will be performed using ultrasound turned off in the thoracolumbar region for 15 minutes followed by rest for 15 minutes for 6 weeks, twice a week. Participants will be evaluated on the first day, fourth week and sixth week of intervention.
Study: NCT05180006

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atezolizumab Injection
Description: Patients randomized to an atezolizumab arm will receive atezolizumab 840 mg IV on D1 (15 days +/- 48 h before the surgery date or the biopsy prior to the start of standard of care neoadjuvant systemic treatment.).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab Injection
Description: Patients randomized to an atezolizumab arm will receive atezolizumab 840 mg IV on D1 (15 days +/- 48 h before the surgery date or the biopsy prior to the start of standard of care neoadjuvant systemic treatment.).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab Injection
Description: Patients randomized to an atezolizumab arm will receive atezolizumab 840 mg IV on D1 (15 days +/- 48 h before the surgery date or the biopsy prior to the start of standard of care neoadjuvant systemic treatment.).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Patients in the atezolizumab plus bevacizumab arm will receive a unique dose of bevacizumab as 10 mg/kg administered by IV infusion over 60 mins on day 1 cycle 1 (15 days before surgery +/- 48 h), the same day as atezolizumab.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pertuzumab
Description: Patients in the atezolizumab plus trastuzumab plus pertuzumab arm will receive single doses of pertuzumab on day 1 administered IV. Pertuzumab will be administered IV at a loading dose of 840 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pertuzumab
Description: Patients in the atezolizumab plus trastuzumab plus pertuzumab arm will receive single doses of pertuzumab on day 1 administered IV. Pertuzumab will be administered IV at a loading dose of 840 mg.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: Patients in the atezolizumab plus trastuzumab plus pertuzumab arm will receive single doses of Trastuzumab on day 1 administered IV. Trastuzumab will be given at a loading dose of 8 mg/kg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: Patients in the atezolizumab plus trastuzumab plus pertuzumab arm will receive single doses of Trastuzumab on day 1 administered IV. Trastuzumab will be given at a loading dose of 8 mg/kg.
Study: NCT06484101

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 3 x 30 seconds of supramaximal exercise
Study: NCT05751070

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bowen Technique
Description: They would be receiving conventional treatment as follow:~Hot pack for 10 minutes TENS for 10 minutes Cervical isometrics 10 reps with 5 sec hold Additionally The Bowen treatment will be 15 to 20 Bowen moves with 2 mins gap between each set for total of 20 mins.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graston technique
Description: They would be receiving conventional treatment as follow:~Hot pack for 10 minutes TENS for 10 minutes Cervical isometrics 10 reps with 5 sec hold Additionally The Graston treatment will be by using lubricant on the skin then a stainless steel instrument to relax the fascia and muscles. The frequency of the plastering and friction movements will be applied in 60 repetitions per minute for total of 20 mins.
Study: NCT05192590

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Materials and Chronic Disease Management Test (CDMT)
Description: Intervention-1- and Intervention-2-arm participants will receive educational materials duplicating what physicians would receive in the real-world market as they adopt the CDMT technology. These materials are comprised of a PowerPoint presentation.~Intervention 1 participants only will receive the CDMT test results whether they select it or not, and Intervention 2 participants will receive the CDMT test results only if they select it during the second round of case simulations.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Materials and Chronic Disease Management Test (CDMT)
Description: Intervention-1- and Intervention-2-arm participants will receive educational materials duplicating what physicians would receive in the real-world market as they adopt the CDMT technology. These materials are comprised of a PowerPoint presentation.~Intervention 1 participants only will receive the CDMT test results whether they select it or not, and Intervention 2 participants will receive the CDMT test results only if they select it during the second round of case simulations.
Study: NCT06047236

Intervention type: OTHER
Intervention: Sampling
Description: Evaluation of immune characteristics by using patient's stool, saliva and blood samples.

Intervention type: OTHER
Intervention: Sampling
Description: Evaluation of immune characteristics by using patient's stool, saliva and blood samples.

Intervention type: OTHER
Intervention: Sampling
Description: Evaluation of immune characteristics by using patient's stool, saliva and blood samples.
Study: NCT04844437

Intervention type: DIAGNOSTIC_TEST
Intervention: Transperineal ultrasound
Description: The fetal head station is evaluated by transperineal ultrasonography in valsalva.
Study: NCT05384665

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: REMIFENTANIL, 5 µg/cc, solution for injection, 0.5 µg/kg, parenteral (intravenous) route, injection delay of 30 seconds, once only

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: SUFENTANIL, 5 µg/cc, solution for injection, 0.2 µg/kg, parenteral (intravenous) route, bolus over 5 seconds, once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: PLACEBO contains 0.9% NaCl, parenteral (intravenous), bolus, one-time

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: PLACEBO contains 0.9% NaCl, parenteral (intravenous), bolus, one-time

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: PLACEBO contains 0.9% NaCl, parenteral (intravenous), bolus, one-time
Study: NCT05310396

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental formula
Description: Cow's milk-based infant formula with a specific blend of nutrients at pre-defined levels

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Formula
Description: Cow's milk-based infant formula with standard nutritional composition
Study: NCT05699122

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gentle intimate hygiene and skin protective barrier application - Persistent erythema with intact epidermis
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), apply skin cleanser without rinsing to finish cleaning, apply a thin layer of Dexpanthenol (with each diaper change), apply polymeric spray solution once a day.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gentle intimate hygiene and skin protective barrier application - Erythema with signs of epidermis loss
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), applying a leave-in skin cleanser to finish cleaning, applying powdered hydrocolloid powder and removing excess. Afterwards, apply a polymeric spray solution.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy - Persistent erythema with intact epidermis
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), apply skin cleanser without rinsing to finish cleaning, apply a thin layer of Dexpanthenol (with each diaper change), apply polymeric spray solution once a day.~It will be associated with the application of Low Intensity Laser Therapy. The entire area affected by DAI will be irradiated with LBI at 1 Joule (J) of energy and with a wavelength of 660nm and 1J with a wavelength of 808nm, which will be applied simultaneously, with a radiance of 20J/cm2 per point, the distance between the stitches will be 1cm long and the application of LLLT will be performed every 24 hours.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Level Laser Therapy - Erythema with signs of epidermis loss
Description: Follow-up will be for 4 days, current treatment will be carried out with:~Perform intimate hygiene with warm water (to remove excess feces and urine), applying a leave-in skin cleanser to finish cleaning, applying powdered hydrocolloid powder and removing excess. Afterwards, apply a polymeric spray solution.~It will be associated with the application of Low Intensity Laser Therapy. The entire area affected by DAI will be irradiated with LBI at 1 Joule (J) of energy and with a wavelength of 660nm and 1J with a wavelength of 808nm, which will be applied simultaneously, with a radiance of 20J/cm2 per point, the distance between the stitches will be 1cm long and the application of LLLT will be performed every 24 hours.
Study: NCT06015555

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TAMO
Description: TAMO therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Postural Control exercises
Description: Postural Control exercises
Study: NCT05194189

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: 12 g vitamin C (48 ml) will be intravenously injected by a infusion pump every 12 h for 4 days or at ICU discharge

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 5% glucose injection
Description: 5% glucose solution 48 ml every 12 h for 4 days or at ICU discharge.
Study: NCT05396092

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated mindfulness-based Tai Chi Chuan
Description: MBTCC will integrate components from both the MBI and TCC groups. The entire intervention consists of eight weekly sessions of two-and-a-half to three hours each.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness-based intervention
Description: The MBI group is mainly based on the basic theory and research of the foundational mindfulness-based stress reduction program. The intervention consists of eight weekly sessions of two to two-and-a-half hours each.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tai Chi Chuan
Description: TCC is mainly based on a nine-form Yang-style form of TCC, which is a brief and modified version of 64-form Yang-style TCC. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Hygiene Education
Description: SHE is based on principles used in stimulus control and sleep hygiene education, which has previously been used as the control group in sleep-related research. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each.
Study: NCT05670002

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Milk supplement
Description: Children will take the milk supplement for a period of 6 months. During the intervention, anthropometry data, Zinc Protoporphyrin levels, dietary intake, any illness will be recorded.
Study: NCT05440383

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KLH-2109
Description: Oral administration

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Leuprorelin
Description: Subcutaneous administration
Study: NCT06149546

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: * High protein, high energy diet~* Fish oil supplement (ProSure®)~* Pancreatic Enzymes (Creon®)~* A daily individualised step target (10% above your own baseline)~* Four scheduled appointments with a dietitian

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Intervention
Description: * High protein, high energy diet~* Fish oil supplement (ProSure®)~* Pancreatic Enzymes (Creon®)~* A daily individualised step target (10% above your own baseline)~* Seven scheduled appointments with a dietitian~* Six scheduled appointments with a physiotherapist
Study: NCT05857111

Intervention type: DEVICE
Intervention: Celbrea
Description: The test with the CELBREA® device will be added to the routine screening according to the protocols of the health facility.
Study: NCT06002191

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Flourish
Description: Flourish is a text messaging program that aims to improve coping following cyberbullying and reduce suicide risk among youth.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires of Online Experiences
Description: Adolescents will receive brief questionnaires related to their online experiences and the impact those experiences have had on their stress level.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires of Online Experiences
Description: Adolescents will receive brief questionnaires related to their online experiences and the impact those experiences have had on their stress level.
Study: NCT05297643

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ekstracorporeal Shock Wave Therapy (ESWT)
Description: Extracorporeal Shock Wave Therapy (ESWT); It is a treatment method in which high-intensity pressure waves are applied to the desired point in the body. It has been used in the treatment of kidney stones in previous years, and changes in bone tissue have been observed (12). Today, it is used in musculoskeletal system diseases such as plantar fasciitis, epicondylitis, achiltendinitis, osteoarthritis

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: complex decongestive therapy
Description: Complex decongestive therapy consists of manual lymphatic degeneration, compression therapy, skin care and remedal exercise.

Intervention type: OTHER
Group type: OTHER
Intervention: complex decongestive therapy
Description: Complex decongestive therapy consists of manual lymphatic degeneration, compression therapy, skin care and remedal exercise.
Study: NCT04995237

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PPP
Description: Participants will be provided with a weekly bag of produce, information about how to cook the produce, assistance in setting quality of life goals, and individualized teaching to support meeting participant's set goals.
Study: NCT04183907

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transform
Description: The Partner, Blue Mesa Health, has developed a lifestyle intervention program for pre-diabetics that aims to prevent or delay the onset of type 2 diabetes through incremental changes to health behaviours. Transform is based on the CDC's National Diabetes Prevention Program (DPP). Blue Mesa Health adapted the National DPP into a digital experience by combining the use of technology- an app, wearable activity trackers (Fitbit) and digital scales- with the professional guidance of remote health coaches.~It is a 6-month intervention that helps individuals establish healthier lifestyle habits. Each participant strives to achieve 2 primary goals:~Attaining 5 to 7 percent weight loss from their starting bodyweight Engaging in at least 150 minutes of weekly physical activity
Study: NCT05041816

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal vibration therapy
Description: Myovolt delivers vibration with a frequency between 60-300 Hz, and acceleration force between 1.8g to 19.1g peak to peak. Myovolt intensity will be set to \~up to 2X the participant's initial Myovolt perception threshold (however, the maximum intensity will be limited to 19.1g which is the maximum intensity the device can deliver). If the stimulation does not feel strong, the participant will be asked to manually increase the intensity until it feels strong but comfortable.
Study: NCT05521555

Intervention type: PROCEDURE
Intervention: Total knee arthroplasty
Description: First intention total knee arthroplasty
Study: NCT04615715

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CMV Risk-Reduction Intervention
Description: CMV Risk-Reduction Intervention

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Stress Reduction Messaging
Description: Stress Reduction Messaging
Study: NCT05073341

Intervention type: OTHER
Group type: OTHER
Intervention: Nurse-led family intervention
Description: Nurse-led family intervention having three components first is infarmation about the patient's condition and guidance will be given to solve there queries and the emotional support will be given to the primary caregivers of CLD patient's admitted in HDU

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nurse-led family intervention
Description: Nurse-led family intervention having three components first is infarmation about the patient's condition and guidance will be given to solve there queries and the emotional support will be given to the primary caregivers of CLD patient's admitted in HDU
Study: NCT04458116

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Curcumin
Description: Participants will receive 1.5 grams of turmeric 95% curcumin for 1 month (3 capsules / day containing 500mg each for 4 weeks).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Curcumin
Description: Participants will receive 1.5 grams of turmeric 95% curcumin for 1 month (3 capsules / day containing 500mg each for 4 weeks).
Study: NCT04791202

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose
Description: See arm descriptions

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone Acetate 40 MG/ML
Description: See arm descriptions